T. Rowe Price Associates’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $56K | Sell |
|
|||||
|
2022
Q4 | $71K | Hold |
|
|||||
|
2022
Q3 | $84K | Hold |
|
|||||
|
2022
Q2 | $148K | Hold |
|
|||||
|
2022
Q1 | $253K | Hold |
|
|||||
|
2021
Q4 | $183K | Buy |
|
|||||
|
2021
Q3 | $196K | Buy |
|
|||||
|
2021
Q2 | $125K | Hold |
|
|||||
|
2021
Q1 | $135K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $37K | Buy |
|